Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

Vanharanta, Sakari, Shu, Weiping, Brenet, Fabienne, Hakimi, A Ari, Heguy, Adriana, Viale, Agnes, Reuter, Victor E, Hsieh, James J-D +2 more·2013·Nature Medicine
DOI 10.1038/nm.3029

Cited by (216)

Items 101–200 of 216

  1. Inhibition of the Hypoxia-Inducible Factor 1α–Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease
    Peter Mirtschink, Corinne Bischof, Minh Duc Pham, Rahul Sharma, Sanjay P. Khadayate, Geetha Rossi, Niklaus Fankhauser, Shuyang Traub, Samuel Tobias Sossalla, Eman Hagag et al. · 2019 · Circulation
  2. Harnessing the genome for characterization of G‐protein coupled receptors in cancer pathogenesis
    Michael E. Feigin · 2013 · FEBS Journal
  3. Histone Deacetylase Inhibitors and Epigenetic Modifications as a Novel Strategy in Renal Cell Carcinoma
    Swathi Ramakrishnan, Роберто Пили · 2013 · The Cancer Journal
  4. Sunitinib activates Axl signaling in renal cell cancer
    Johannes Cornelis van der Mijn, Henk J. Broxterman, Jaco C. Knol, Sander R. Piersma, Richard R. de Haas, Henk Dekker, Thang V. Pham, Victor W. van Beusechem, Balázs Halmos, James Walter Mier et al. · 2016 · International Journal of Cancer
  5. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance
    Kateryna I. Kubaichuk, Thomas Kietzmann · 2019 · Cells
  6. Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro
    Cen Xie, Xiaoxia Gao, Dongxue Sun, You-Bo Zhang, Kristopher W. Krausz, Xuemei Qin, Frank J. Gonzalez · 2018 · Drug Metabolism and Disposition
  7. The up‐regulation of NDRG1 by HIF counteracts the cancer‐promoting effect of HIF in VHL‐deficient clear cell renal cell carcinoma
    Zheng‐Yan Zhang, Shilong Zhang, Hui‐Ling Chen, Yuqin Mao, Zhan‐Ming Li, Chao‐Yue Kong, Bing Han, Jin Zhang, Yonghui Chen, Wei Xue et al. · 2020 · Cell Proliferation
  8. Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities
    Minhong Shen, Yibin Kang · 2020 · Genes & Development
  9. ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer
    Ke Chen, Yu Gan, Kiranmai Gumireddy, Anping Li, Weimin Yao, Lu Gao, Shuliang Chen, Jun Hao, Ji Wang, Qihong Huang et al. · 2015 · Oncotarget
  10. Phenotypic plasticity and epithelial‐to‐mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma
    Navin Vig, Ian Campbell Mackenzie, Adrian Biddle · 2015 · Journal of Oral Pathology and Medicine
  11. Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles
    Samjhana Shrestha, Asmita Banstola, Jee‐Heon Jeong, Ji Hae Seo, Simmyung Yook · 2022 · Journal of Controlled Release
  12. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
    Maxime Janin, Verónica Dávalos, Manel Esteller · 2023 · Cancer and Metastasis Reviews
  13. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway
    Ting Liu, Le Zhao, Wei Chen, Zhen Li, Huilian Hou, Lu Ding, Li Xu · 2014 · International Journal of Molecular Medicine
  14. The circadian clock and the hypoxic response pathway in kidney cancer
    Gianluigi Mazzoccoli, Angelo De Cata, Ada Piepoli, Manlio Vinciguerra · 2013 · Tumor Biology
  15. VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α
    Feng‐Qiang Yang, Min Liu, Fengping Yang, Jian‐Ping Che, Wei Li, Wei Zhai, Guangchun Wang, Junhua Zheng, Xi Li · 2014 · Molecular Biology Reports
  16. Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
    Hossein Tezval, Natalia Dubrowinskaja, Inga Peters, Christel Reese, Katrin Serth, Faranaz Atschekzei, Jörg Hennenlotter, Arnulf Stenzl, Markus Antonius Kuczyk, Jürgen Serth · 2016 · PLoS ONE
  17. Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma
    Robert H.I. Andtbacka, Yan Wang, Robert Hamilton Pierce, Jean S. Campbell, Melinda Lynne Yushak, Mohammed M. Milhem, Merrick Ross, Katie Niland, Robert D. Arbeit, Sudha Parasuraman et al. · 2022 · Cancer Research Communications
  18. The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
    Boren Tian, Xiaoyun Du, Shiyu Zheng, Yan Zhang · 2022 · International Journal of Molecular Sciences
  19. High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
    H An, Lei Xu, Yu Zhu, Tao� Lv, W. Liu, Y Liu, H Liu, L Chen, Jun Xu, Z Lin · 2014 · British Journal of Cancer
  20. The Physics of Cancer
    Caterina A. M. La Porta, Stefano Zapperi · 2017 · Cambridge University Press eBooks
  21. Consequences of VHL Loss on Global DNA Methylome
    Robinson, Claire M., Lefebvre, Francois, Poon, Betty P., Bousard, Aurelie, Fan, Xiaojun, Lathrop, Mark, Tost, Jorg, Kim, William Y., Riazalhosseini, Yasser, Ohh, Michael · 2018 · Scientific Reports
  22. Complex role of HIF in cancer: the known, the unknown, and the unexpected
    Eric L. Huang, Patricia D.B. Tiburcio, Hyunsung Choi · 2014 · Hypoxia
  23. Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation
    Girolamo Ranieri, Ilaria Marech, Artor Niccoli Asabella, Alessandra Di Palo, Mariangela Porcelli, Valentina Lavelli, Giuseppe Rubini, Cristina Ferrari, Cosmo Damiano Gadaleta · 2017 · International Journal of Molecular Sciences
  24. Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus
    Haiyang Yu, Na Shen, Yanli Bao, Li Chen, Zhaohui Tang · 2019 · Biomaterials Science
  25. TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
    Lennart Versemann, Shilpa Patil, Benjamin Steuber, Zhe Zhang, Waltraut Kopp, Hannah Elisa Krawczyk, Silke Kaulfuß, Bernd Wollnik, Philipp Ströbel, Albrecht Neeße et al. · 2022 · Cancers
  26. Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
    Grant Duncan Stewart, Thomas B. Powles, Christophe Van Neste, Alison M. Meynert, Fiach C. O’Mahony, Alexander Laird, Dieter L. D. Deforce, Filip Van Nieuwerburgh, Geert Trooskens, Wim Van Criekinge et al. · 2016 · Oncotarget
  27. Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma
    Zhouji Shen, Ling Zhu, Chao Zhang, Xiaobo Cui, Jun Lü · 2019 · Oncology Reports
  28. ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis
    Ruishan Wang, Akshita B. Bhatt, Benjamin A. Minden‐Birkenmaier, Olivia K. Travis, Srishti Tiwari, Hong Jia, Wojciech Rosikiewicz, Ophelie Martinot, Eleanor Childs, Robin Loesch et al. · 2023 · Science Advances
  29. Biomarker-informed care for patients with renal cell carcinoma
    M. Mckinnon, Brian I. Rini, Scott Mattox Haake · 2025 · Nature Cancer
  30. Reduced ING1 levels in breast cancer promotes metastasis
    Satbir Singh Thakur, Arvind K. Singla, Jie Chen, Uyen Tran, Yang Yang, Carolina Salazar, Anthony Martin Magliocco, Alexander C. Klimowicz, Frank Robert Jirik, Karl T. Riabowol · 2014 · Oncotarget
  31. The genetic script of metastasis
    Goodwin G. Jinesh, Andrew Scott Brohl · 2019 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  32. Diverse Neoantigens and the Development of Cancer Therapies
    Raghvendra Mohan Srivastava, Tanaya A. Purohit, Timothy An-thy Chan · 2020 · Seminars in Radiation Oncology
  33. Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs
    Ram N Ganapathi, Mahrukh K. Ganapathi · 2013 · Urologic Oncology Seminars and Original Investigations
  34. Identification of PDE7B as a Potential Core Gene Involved in the Metastasis of Clear Cell Renal Cell Carcinoma
    Yi Eve Sun, Junxia Zou, Wei Ouyang, Ke Chen · 2020 · Cancer Management and Research
  35. Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells
    Viktor Malec, Judy M. Coulson, Sylvie Urbé, Michael J. Clague · 2015 · Journal of Proteome Research
  36. New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities
    Beatrice Cesana, Claude Cochet, Odile Filhol · 2024 · International Journal of Cancer
  37. Research advances on epigenetics and cancer metabolism
    Hengyi Han, Fan Feng, Haitao Li · 2021 · Journal of Zhejiang University (Medical Sciences)
  38. VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
    Xueyou Ma, Zenglai Tan, Qin Zhang, Kaifang Ma, Jun Xiao, Xiong Wang, Yanan Wang, Mengjie Zhong, Yu Wang, Jing Li et al. · 2022 · Cell & Bioscience
  39. A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization
    A M Nowicka, Irina Häuselmann, Lubor Borsig, Sebastian Bolduan, Michael Schindler, Peter Schraml, Mathias F Heikenwälder, Holger Moch · 2015 · Oncogene
  40. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer
    Louis Y. El Khoury, Shuang Fu, Ryan A. Hlady, Ryan T. Wagner, Liguo Wang, Jeanette E. Eckel‐Passow, Erik P. Castle, Melissa Stanton, Robert Houston Thompson, Alexander Scott Parker et al. · 2021 · Clinical Epigenetics
  41. Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
    Xuechun Wang, Jin Hu, Yihao Fang, Yanbin Fu, Bing Liu, Chao Zhang, Shan Feng, Xin Lü · 2022 · Cells
  42. Molecular Biology of Kidney Cancer
    William G. Kaelin · 2015 · Springer eBooks
  43. Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome
    Louis Y. El Khoury, Xiaoyu Pan, Ryan A. Hlady, Ryan T. Wagner, Shafiq Shaikh, Liguo Wang, Mitchell R. Humphreys, Erik P. Castle, Melissa Stanton, Thai H. Ho et al. · 2023 · Clinical Epigenetics
  44. Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization
    Banumathy Gowrishankar, Lynnette M. Cahill, Alexandra E. Arndt, Hikmat A Al‐Ahmadie, Oscar Lin, Kalyani Chadalavada, Seeta R. Chaganti, Gouri J. Nanjangud, Vundavalli V.V.S. Murty, Raju S. K. Chaganti et al. · 2014 · British Journal of Urology
  45. Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions
    Teresa W.‐M. Fan, Jahid M.M. Islam, Richard M. Higashi, Penghui Lin, Christine F. Brainson, Andrew N. Lane · 2023 · Journal of Biological Chemistry
  46. PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition
    Yating Sun, Dan Li, Hongmei Liu, Yongye Huang, Fanyu Meng, Jiahao Tang, Zhanjun Li, Wanhua Xie · 2022 · Cell Death and Disease
  47. A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options
    Ivana Jochmanová, Ivica Lazúrová · 2014 · Biomedical Papers
  48. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
    Johannes Cornelis van der Mijn, Kenneth Eng, Pooja Chandra, Evan M. Fernandez, Sinan Ramazanoglu, Alexandros Sigaras, Clara Oromendia, Lorraine J. Gudas, Scott T. Tagawa, David M. Nanus et al. · 2022 · Molecular Oncology
  49. Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma
    Asmaa Y. Abuhamad, Nurul Nadia Mohamad Zamberi, Sakari Vanharanta, Siti Nur Hasanah Mohd Yusuf, M. Aiman Mohtar, Saiful Effendi Syafruddin · 2023 · International Journal of Molecular Sciences
  50. The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5
    Man Zhao, Dalin Zhang, Haowen Jiang, Nishanth Kuganesan, Suchitra Natarajan, Leighton Pu, Kaushik N. Thakkar, Hongjuan Zhao, Quynh‐Thu Le, Amato J. Giaccia et al. · 2025 · Science Advances
  51. Monitoring Chemokine Receptor Trafficking by Confocal Immunofluorescence Microscopy
    Adriano Marchese · 2015 · Methods in enzymology on CD-ROM/Methods in enzymology
  52. Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
    Esther Arnaiz, Ana Miar, Esther Bridges, Naveen Prasad, Stephanie B. Hatch, Daniel V. Ebner, Charles Henderson Lawrie, Adrian Llewellyn Harris · 2021 · BMC Cancer
  53. Hypoxia Signaling—License to Metastasize
    Sakari Vanharanta, Joan Massagué · 2013 · Cancer Discovery
  54. The signaling pathway of hypoxia inducible factor and its role in renal diseases
    Song Mao, Songming Huang · 2013 · Journal of Receptors and Signal Transduction
  55. PBX1, EMCN and ERG are associated with the sub-clusters and the prognosis of VHL mutant clear cell renal cell carcinoma
    Haiwei Wang, Xinrui Wang, Liangpu Xu, Ji Zhang · 2022 · Scientific Reports
  56. Epigenetic markers and therapeutic targets for metastasis
    Carolyn J. Kravitz, Qin Yan, Don X. Nguyen · 2023 · Cancer and Metastasis Reviews
  57. Personalized Medicine for Nervous System Manifestations of von Hippel–Lindau Disease
    Victoria A. Schunemann, Kristin Michelle Huntoon, Russell R. Lonser · 2016 · Frontiers in Surgery
  58. Characterization of RNA editome in primary and metastatic lung adenocarcinomas
    Lihua Peng, Leo J. Lee, Heng Xiong, Hong Lin Su, Jun-Hua Rao, Dakai Xiao, Jianxing He, Kui Wu, Dongbing Liu · 2016 · Oncotarget
  59. Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells
    Guang Chen, Jinye Xu, Jie Chen, Jian-Xin Zhang, Jun Zhou, Yong Liang, Xiaofei Ding · 2016 · Oncotarget
  60. Cytohesin-associated scaffolding protein (CASP) is involved in migration and IFN-γ secretion in Natural Killer cells
    Nicholas Tompkins, Brian R. MacKenzie, Collin Ward, David Salgado, Andrew M. Leidal, Craig McCormick, Bill Pohajdak · 2014 · Biochemical and Biophysical Research Communications
  61. The SWI/SNF complex member SMARCB1 supports lineage fidelity in kidney cancer
    Ludovic Wesolowski, Jianfeng Ge, Leticia Castillon, Debora Sesia, Anna Dyas, Shoko Hirosue, Veronica Caraffini, Anne Yvonne Warren, Paulo Rodrigues, Giovanni Ciriello et al. · 2023 · iScience
  62. Bevacizumab as First-Line Therapy for Patients With Brain Metastases From Renal Carcinoma: A Case Series
    Fable Zustovich, Alessandra Ferro, Patrizia Farina · 2014 · Clinical Genitourinary Cancer
  63. Microarray Profiling of Human Renal Cell Carcinoma: Identification for Potential Biomarkers and Critical Pathways
    Wei Li, Wei Zhu, Jian‐Ping Che, Wei Sun, Min Liu, Bo Peng, Junhua Zheng · 2013 · Kidney & Blood Pressure Research
  64. The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
    Treg M. Grubb, Pooneh Koochaki, Sayed Matar, Fatme Ghandour, Marc Machaalani, Eddy Saad, Cerise Tang, Ed Reznik, Jesminara Khatun, Carleigh Salem et al. · 2025 · Nature Communications
  65. Low EGR1 expression predicts poor prognosis in clear cell renal cell carcinoma
    Zhengyan Zhang, Shilong Zhang, Huiling Chen, Yuqin Mao, Chao‐Yue Kong, Zhanming Li, Li‐Shun Wang, Ming Ma, Bing Han · 2021 · Pathology - Research and Practice
  66. von Hippel-Lindau Exonic Methylation Analysis Using MALDI-TOF Mass Spectrometry
    Fei Lian, Shilpa Sreedharan, Rebecca S. Arnold, Viraj A. Master, Kenneth Ogan, John G. Pattaras, David L. Roberts, John A. Petros · 2014 · The Journal of Urology
  67. Nitrogen partitioning between branched-chain amino acids and urea cycle enzymes sustains renal cancer progression
    Marco Sciacovelli, Aurélien J. F. Dugourd, Lorea Valcárcel-Jiménez, Ming Hui Yang, Efterpi Nikitopoulou, Ana S.H. Costa, Laura Tronci, Veronica Caraffini, Paulo Rodrigues, Christina Schmidt et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  68. S‐(4‐Methoxyphenyl)‐4‐methoxybenzenesulfonothioate as a Promising Lead Compound for the Development of a Renal Carcinoma Agent
    Camilla I. Nantes, Ingrid D. Pereira, Ruoli Bai, Ernest Hamel, James C. Burnett, Rodrigo Juliano Oliveira, Maria de Fátima Cepa Matos, Adilson Beatriz, Murilo K. A. Yonekawa, Renata Trentin Perdomo et al. · 2019 · ChemMedChem
  69. Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities
    Jianfeng Ge, Shoko Hirosue, Leticia Castillon, Saroor A. Patel, Ludovic Wesolowski, Anna Dyas, Cissy Yong, Sanne de Haan, Jarno Drost, Grant Duncan Stewart et al. · 2025 · EMBO Molecular Medicine
  70. Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma
    Changzheng Zhang, Jiayi Zeng, Chujin Ye, Kaiwen Tian, Zhiyong Xian · 2024 · Translational Cancer Research
  71. Molecular Biology of Kidney Cancer
    William G. Kaelin · 2011 · Springer eBooks
  72. Molecular Genetics of Renal Cell Carcinoma
    Tomoya Fukawa, Nicholas Brian Shannon, Dachuan Huang, Jing Ying Tan, Xiaosai Yao, Steve Rozen, Patrick Tan, Bin Tean Teh · 2017 · Springer eBooks
  73. Endogenous HIF2A reporter systems for high-throughput functional screening
    M. Nazhif Zaini, Saroor A. Patel, Saiful Effendi Syafruddin, Paulo Rodrigues, Sakari Vanharanta · 2018 · Scientific Reports
  74. Lineage-Specific Transcription Factors in Carcinogenesis
    Charles J. David, Sakari Vanharanta · 2024 · Annual Review of Cancer Biology
  75. Activation of RHO-GTPase gene pattern correlates with adverse clinical outcome and immune microenvironment in clear cell renal cell carcinoma
    Kehang Guo, Pengyue Ma, Qi Yang, Lingli Xu, Biixiong Zhang, Hong Zhang, Zhongwen Zheng, Zewei Zhuo · 2025 · Clinical and Experimental Medicine
  76. Targeting GABARAPL1/HIF-2a axis to induce tumor cell apoptosis in nasopharyngeal carcinoma.
    Xiaopeng Huang, Liya Zhou, Jiawei Chen, Shuai Zhang · 2024 · PubMed Central
  77. Inhalational Anesthetic Agents and Their Effects on Cancer Cell Biology
    Nicholas J. S. Perry, Daqing Ma · 2015 · Current anesthesiology reports
  78. Characterization of Clear Cell Renal Cell Carcinoma with a Wild-type von Hippel-Lindau Tumor Suppressor Gene: Limitation of Survival Expectations Using Single-gene Alteration
    Keiichi Kondo, Masahiro Yao · 2015 · European Urology Focus
  79. SWI/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers
    Jin Zhou, Austin J. Hepperla, Jeremy M. Simon, Kangsan Kim, Qing Hu, Chuanhai Zhang, Lei Dong, Lianxin Hu, Cheng Zhang, Chengheng Liao et al. · 2025 · Nature Communications
  80. Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma
    Cissy Yong, Christina Schmidt, Ming Hui Yang, Alex von Kriegsheim, Anne Yvonne Warren, Shubha Anand, James N. Armitage, Antony C. P. Riddick, Thomas J. Mitchell, Vishal Patil et al. · 2025 · Nature Communications
  81. BCL-XL dependence is a subtype agnostic actionable feature of difficult-to-treat kidney cancers
    Tupa Basuroy, Treg M. Grubb, Ananthan Sadagopan, Xingping Qin, Kylee Madison, Autumn Hall, Belinda B. Willard, Sakari Vanharanta, Kristopher A. Sarosiek, Srinivas R. Viswanathan et al. · 2026 · Cell Death and Disease
  82. Investigation of the Role of microRNA Associated with the VHL-HIFα-Dependent Pathway in Patients with Clear Cell Renal Cell Carcinoma
    Elizaveta A. Klimentova, I. R. Gilyazova, Marina Bermisheva, А. М. Блинникова, Ruslan I. Safiullin, Адель Альбертович Измайлов, Baofeng Yang, В. Н. Павлов, Э. К. Хуснутдинова · 2020 · Russian Journal of Genetics
  83. Cancer
    Harold I. Zeliger · 2022 · Elsevier eBooks
  84. Preclinical Models of Brain Metastasis
    Lucía Zhu, Manuel Valiente · 2020 · Springer eBooks
  85. Molecular Determinants of Metastasis in Renal Cell Cancer: Tracking Down the Real Killer
    Richard J. Lee · 2015 · The Journal of Urology
  86. RNA-sequencing analysis in B-cell acute lymphoblastic leukemia reveals aberrant gene expression and splicing alterations
    Olha Kholod · 2017
  87. Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancer
    Dig Vijay Kumar Yarlagadda, Zhenghan Wang, Hui Jiang, Lynda H. Vuong, Andrea López Sanmiguel, Ching-Yeuh Yang, Ritesh R. Kotecha, Ying‐Bei Chen, A. Ari Hakimi, Christina S. Leslie et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Going places with VHL
    Nicola Jane McCarthy · 2012 · Nature reviews. Cancer
  89. From molecular understanding to clinical advances
    Chung‐Han Lee, Robert John Motzer · 2013 · Nature Reviews Urology
  90. A regulatory network of Mdm2 and members of the Polycomb Group (PcG) family
    Maria Magdalena Wienken · 2016
  91. A possible IDO1- TSP1 role in breast cancer dormancy
    Bruno Lopes-Bastos · 2017 · ORCA Online Research @Cardiff (Cardiff University)
  92. Endogenous Reporter Systems for High-Throughput Functional Screening in Clear Cell Renal Cell Carcinoma
    M. Nazhif Zaini · 2019 · Apollo (University of Cambridge)
  93. Faculty Opinions recommendation of Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.
    Andrew C. Dudley · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  94. EZH2-GATA6 axis in Pancreatic ductal adenocarcinoma
    Shilpa Patil · 2020
  95. TP53-status dependent oncogenic EZH2 Activity in Pancreatic Cancer
    Lennart Versemann · 2022
  96. Targeting GABARAPL1/HIF-2a in nasopharyngeal carcinoma
    Xiaopeng Huang, Liya Zhou, Jiawei Chen, Shuai Zhang · 2023 · Research Square
  97. Additional file 7 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
    Xueyou Ma, Zenglai Tan, Qin Zhang, Kaifang Ma, Jun Xiao, Xiong Wang, Yanan Wang, Mengjie Zhong, Yu Wang, Li, Jing et al. · 2022 · Figshare
  98. Comparative single‐cell transcriptomic profiling of patient‐derived renal carcinoma cells in cellular and animal models of kidney cancer
    Richard Huang, Lynn Kee, Alexander Gont, Jalna Meens, Fraser G. Ferens, Meredith S. Irwin, Laurie Ailles, Scott A. Yuzwa, Claire M. Robinson, Michael Ohh · 2025 · FEBS Open Bio
  99. Genotype-phenotype correlation in Iranian retinal hemangioblastoma patients and genetic diagnosis algorithm for Von Hippel-Lindau disease
    Fatemeh Azimi, Masood Naseripour, Golnaz Khakpoor · 2025 · Ophthalmic Genetics
  100. Reactive oxygen species (ROS) and late-stage cancer (Cancer metastasis)
    Milena Krajnović, Snežana Jovanović-Ćupić, Bojana Kožik, Ana Božović · 2025 · Elsevier eBooks